Stocktoria
Hongchang International Co., Ltd HCIL
OTC · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1999-11-05
Hongchang International Co., Ltd financials (annual)
Bars are annual figures from 2014 to 2024; red bars are negative (a loss or cash outflow).
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.9M | $2.7M | $78,953 | $96,478 | $222,701 | $163,680 | — | — | $3.2M | $6.6M |
| Gross profit | $181,632 | $69,358 | $51,568 | $66,163 | $104,176 | $80,101 | — | — | $385,607 | $1.7M |
| R&D expense | — | — | — | — | — | — | — | — | $214,851 | $225,011 |
| Operating income | -$383,326 | -$469,572 | -$239,992 | -$162,836 | -$278,783 | -$538,124 | -$247,777 | -$54,113 | -$1.6M | -$509,379 |
| Interest expense | — | — | — | — | — | — | — | — | $1,182 | — |
| Income tax | -$22,303 | -$65,905 | — | — | — | — | — | — | — | — |
| Net income | — | -$378,794 | -$239,989 | -$163,020 | -$548,396 | -$488,386 | -$250,344 | -$54,113 | -$3.5M | -$498,818 |
| EPS (diluted) | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | $0.00 | $-0.07 | $-0.01 |
| Operating cash flow | -$7.3M | $750,521 | -$225,774 | -$141,144 | -$21,849 | -$546,626 | -$265,263 | -$41,300 | -$378,376 | -$1.6M |
| Free cash flow | -$11.4M | -$39.8M | — | — | — | — | — | — | — | -$1.6M |
| Cash & equivalents | — | $895,730 | $3,141 | $4,323 | — | $95,522 | $37,555 | $0 | $178,187 | $609,313 |
| Inventory | — | $13,713 | — | — | $501,364 | $421,533 | — | — | $18,942 | $20,289 |
| Total assets | $57.5M | $50.2M | $31.2M | $93,549 | $194,294 | $852,453 | $58,879 | $0 | $426,533 | $4.1M |
| Total liabilities | $18.7M | $9.7M | $31.7M | $1.9M | $1.8M | $1.6M | $296,115 | $54,113 | $268,027 | $393,845 |
| Shareholders' equity | $38.8M | $40.5M | -$418,653 | -$1.8M | -$1.6M | -$767,941 | -$237,236 | -$54,113 | -$1.2M | $3.7M |
Growth · year-over-year · Revenue CAGR -11.2%
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +7.1% | +3289.1% | -18.2% | -56.7% | +36.1% | — | — | — | -51.7% | +295.3% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2024-12-31. Facts plus Stocktoria's own computed scores — not investment advice.